Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
monoclonal antibody used to preventrejection inorgan transplantation , especially inkidney transplants .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word basiliximab.
Examples
-
The transplant drug works as part of a combination therapy with cyclosporine, basiliximab, and corticosteroids.
Social Security Reports, News and Informaion MedPageToday.com - medical news plus CME for physi 2010
-
In our recently reported prospective, randomized, international clinical trial comparing rabbit antithymocyte globulin and basiliximab in renal transplantation (ClinicalTrials. gov number, NCT00235300 [ClinicalTrials. gov]) ,1 we observed that induction treatment with rabbit antithymocyte globulin was as safe as and more effective than basiliximab at 1 year in preventing acute rejection in patients who had received kidney transplants from deceased donors and who were at increased risk for acute rejection or delayed graft function.
-
In our recently reported prospective, randomized, international clinical trial comparing rabbit antithymocyte globulin and basiliximab in renal transplantation (ClinicalTrials. gov number, NCT00235300 [ClinicalTrials. gov]) ,1 we observed that induction treatment with rabbit antithymocyte globulin was as safe as and more effective than basiliximab at 1 year in preventing acute rejection in patients who had received kidney transplants from deceased donors and who were at increased risk for acute rejection or delayed graft function.
-
Whether the apparent benefits of rabbit antithymocyte globulin over basiliximab persist is unknown.
-
Whether the apparent benefits of rabbit antithymocyte globulin over basiliximab persist is unknown.
-
Whether the apparent benefits of rabbit antithymocyte globulin over basiliximab persist is unknown.
-
In our recently reported prospective, randomized, international clinical trial comparing rabbit antithymocyte globulin and basiliximab in renal transplantation (ClinicalTrials. gov number, NCT00235300 [ClinicalTrials. gov]) ,1 we observed that induction treatment with rabbit antithymocyte globulin was as safe as and more effective than basiliximab at 1 year in preventing acute rejection in patients who had received kidney transplants from deceased donors and who were at increased risk for acute rejection or delayed graft function.
-
In our recently reported prospective, randomized, international clinical trial comparing rabbit antithymocyte globulin and basiliximab in renal transplantation (ClinicalTrials. gov number, NCT00235300 [ClinicalTrials. gov]) ,1 we observed that induction treatment with rabbit antithymocyte globulin was as safe as and more effective than basiliximab at 1 year in preventing acute rejection in patients who had received kidney transplants from deceased donors and who were at increased risk for acute rejection or delayed graft function.
-
In our recently reported prospective, randomized, international clinical trial comparing rabbit antithymocyte globulin and basiliximab in renal transplantation (ClinicalTrials. gov number, NCT00235300 [ClinicalTrials. gov]) ,1 we observed that induction treatment with rabbit antithymocyte globulin was as safe as and more effective than basiliximab at 1 year in preventing acute rejection in patients who had received kidney transplants from deceased donors and who were at increased risk for acute rejection or delayed graft function.
-
Whether the apparent benefits of rabbit antithymocyte globulin over basiliximab persist is unknown.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.